Monday November 23 2009 | Biotechnology feed | All feeds
|
|
Target Discovery, Inc.
Download detailed PDF Members: Target Discovery discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. A growing body of scientific literature shows that protein isoforms correlate more precisely with disease state and patient-specific treatment response than current clinical biomarkers. Most protein isoforms (90%) are made by the body after the protein is produced (post-translational modifications). Such protein modifications remain largely inaccessible to current immunodiagnostic and nucleic acid clinical assays. Target Discovery's Isonostic™ products are designed to make this isoform biomarker information accessible to clinicians.
This page has been viewed 394 times since April 2007, the link to the organisation's website has been followed 58 times Recent Search Terms used to find this page: target discovery palo alto | . Search for more companies in Palo Alto Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Target Discovery, Inc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|